LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c

LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Western Digital (WDC) call put ratio 1 call to 1.2 puts on 57K contracts
• Kushner: conversations between U.S. and different areas of Iran govt are more robust than it has every been